Internal Medicine, Interventional Cardiology · Owensboro, KY
NPI
1093820953
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
3110 Fairview Dr
Owensboro, KY, 42303
Phone (270) 240-2129
Groups this clinician bills Medicare through
Medicare paid, 2024
$848K
18,072 services
Medicare patients, 2024
2,494
Average age 76
Drug cost, 2024
$4.1M
23,655 prescriptions
Company payments, 2025
$665
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roshan K Mathew was code 99214 (office e&m - established), 2,992 times for 1,871 patients. In total Roshan K Mathew billed 18,072 services in 93 codes, and Medicare paid $848K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,992 | 1,871 | $84.65 | $253K |
| 93793 Care Management/Coordination | Office | 2,012 | 137 | $7.92 | $16K |
| 93000 Electrocardiogram | Office | 1,669 | 1,487 | $9.49 | $16K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,557 | 390 | $6.42 | $9,997 |
| 80048 Clinical Chemistry | Office | 919 | 580 | $8.24 | $7,571 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 914 | 456 | $56.35 | $52K |
| 93306 Echocardiography (TTE/TEE) | Office | 885 | 850 | $134.59 | $119K |
| 36415 Venipuncture Blood Collection | Office | 734 | 440 | $8.65 | $6,349 |
| 85025 Blood Count | Office | 706 | 508 | $7.59 | $5,359 |
| 78452 Myocardial Perfusion Scan | Office | 474 | 473 | $320.47 | $152K |
| 93015 Electrocardiogram | Office | 471 | 469 | $48.98 | $23K |
| 83735 Clinical Chemistry | Office | 434 | 352 | $6.56 | $2,845 |
| 83880 Clinical Chemistry | Office | 412 | 289 | $38.47 | $16K |
| 99213 Office E&M - Established | Office | 398 | 391 | $53.92 | $21K |
| 80076 Clinical Chemistry | Office | 392 | 325 | $7.97 | $3,125 |
By year: 2022 $1.1M for 20,496 services; 2023 $1.1M for 20,349 services; 2024 $848K for 18,072 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80048 Clinical Chemistry | 919 | 580 | $8.24 | $7,571 |
| 36415 Venipuncture Blood Collection | 734 | 440 | $8.65 | $6,349 |
| 85025 Blood Count | 706 | 508 | $7.59 | $5,359 |
| 83735 Clinical Chemistry | 434 | 352 | $6.56 | $2,845 |
| 83880 Clinical Chemistry | 412 | 289 | $38.47 | $16K |
| 80076 Clinical Chemistry | 392 | 325 | $7.97 | $3,125 |
| 85610 Clinical Chemistry | 216 | 152 | $4.20 | $907 |
| 84443 Clinical Chemistry | 196 | 190 | $16.39 | $3,212 |
| 84439 Clinical Chemistry | 195 | 190 | $8.80 | $1,716 |
| 85730 Clinical Chemistry | 114 | 102 | $5.89 | $671 |
Medicare prescription drug claims, 2024
In 2024, the drug Roshan K Mathew prescribed most often to Medicare patients was Clopidogrel (Clopidogrel Bisulfate), with 2,364 prescriptions and refills. In total Roshan K Mathew wrote 23,655 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clopidogrel Clopidogrel Bisulfate | 2,364 | 6,066 | 683 | $22K |
| Metoprolol Succinate Generic | 2,077 | 5,368 | 601 | $23K |
| Eliquis Apixaban | 1,975 | 3,683 | 421 | $2.1M |
| Amlodipine Besylate Generic | 1,691 | 4,312 | 513 | $7,990 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 1,265 | 2,950 | 370 | $11K |
| Warfarin Sodium Generic | 1,222 | 1,457 | 170 | $5,823 |
| Losartan Potassium Generic | 933 | 2,342 | 274 | $8,103 |
| Lisinopril Generic | 794 | 2,134 | 237 | $4,252 |
| Atorvastatin Calcium Generic | 676 | 1,876 | 205 | $4,234 |
| Metoprolol Tartrate Generic | 652 | 1,660 | 182 | $2,524 |
| Carvedilol Generic | 634 | 1,682 | 178 | $4,078 |
| Furosemide Generic | 528 | 1,310 | 175 | $1,883 |
| Hydralazine Hcl Generic | 506 | 1,254 | 171 | $5,459 |
| Rosuvastatin Calcium Generic | 503 | 1,300 | 143 | $5,652 |
| Xarelto Rivaroxaban | 486 | 984 | 112 | $534K |
Brand drugs: 3,935 claims; generic drugs: 19,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roshan K Mathew $665 ($665 in general payments such as food, travel and fees) from 13 companies. The largest payer was Merck Sharp & Dohme LLC with $119.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $82.52 |
| Philips North America LLC PHG | 4 | $77.7 |
| Abbott Laboratories ABT | 1 | $72.86 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $57.83 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $50.11 |
| Pfizer Inc. PFE | 2 | $49.49 |
| Abiomed JNJ | 2 | $40.94 |
| Medtronic, Inc. MDT | 2 | $39.53 |
| Teleflex LLC TFX | 1 | $22.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.